⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDGL News
Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
globenewswire.com
MDGL
Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Form 8-K
sec.gov
MDGL
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
MDGL
Condor Software Launches Advanced Analytics and Dynamic Scenario Suite
prnewswire.com
ACAD
BBIO
MDGL
Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline
globenewswire.com
MDGL